UK Secretary of State – Roche, REGN-COV2 Supply Agreement Post author:GHIAA Editor Post published:June 30, 2021 Post category: Continue ReadingUK Secretary of State – Roche, REGN-COV2 Supply Agreement
Peru Ministry of Health – Pfizer/BioNTech, COVID-19 Vaccine Binding Term Sheet Post author:GHIAA Editor Post published:June 28, 2021 Post category: Continue ReadingPeru Ministry of Health – Pfizer/BioNTech, COVID-19 Vaccine Binding Term Sheet
Dominican Republic Ministry of Health – Pfizer/BioNTech, COVID-19 Vaccine Binding Term Sheet Post author:GHIAA Editor Post published:June 3, 2021 Post category: Continue ReadingDominican Republic Ministry of Health – Pfizer/BioNTech, COVID-19 Vaccine Binding Term Sheet
UK Secretary of State – AstraZeneca, COVID-19 Vaccine Supply Agreement Post author:GHIAA Editor Post published:May 28, 2021 Post category: Continue ReadingUK Secretary of State – AstraZeneca, COVID-19 Vaccine Supply Agreement
CEPI – Novavax, COVID-19 Vaccine Funding Agreement Post author:GHIAA Editor Post published:May 14, 2021 Post category: Continue ReadingCEPI – Novavax, COVID-19 Vaccine Funding Agreement
CEPI – Novavax, COVID-19 Vaccine Funding Agreement Post author:GHIAA Admin Post published:May 14, 2021 Post category: Continue ReadingCEPI – Novavax, COVID-19 Vaccine Funding Agreement
Israel – Pfizer Real-World Epidemiological Evidence Collaboration Agreement Post author:GHIAA Editor Post published:May 11, 2021 Post category: Continue ReadingIsrael – Pfizer Real-World Epidemiological Evidence Collaboration Agreement
US Army Contracting Command (via ATI) – Regeneron, COVID-19 Antibodies Large-Scale Manufacturing Agreement Post author:GHIAA Admin Post published:April 16, 2021 Post category: Continue ReadingUS Army Contracting Command (via ATI) – Regeneron, COVID-19 Antibodies Large-Scale Manufacturing Agreement
US Department of Defense – Novavax, COVID-19 Vaccine Development Agreement Post author:GHIAA Admin Post published:March 23, 2021 Post category: Continue ReadingUS Department of Defense – Novavax, COVID-19 Vaccine Development Agreement